Matthew R. Moll, MD, MPH
Research Areas: polygenic risk prediction, omics risk prediction, multiple omics, drug repurposing, systems pharmacology, COPD, asthma, pulmonary fibrosis
Dr. Moll is an Assistant Professor of Medicine at the Channing Division of Network Medicine, Associate Physician in the Division of Pulmonary and Critical Care Medicine at Brigham and Women’s Hospital and Harvard Medical School, and a physician at the VA Boston Healthcare System.
He received his undergraduate degree from Michigan State University, his medical degree from Penn State, and a Master of Public Health in Quantitative Methods from the T.H. Chan Harvard School of Public Health. He completed his residency in internal medicine at Boston University Medical Center and his clinical fellowship at Brigham and Women’s Hospital, followed by a postdoctoral fellowship at the Channing Division of Network Medicine. His research focuses on using genetics and other Omics in early identification and therapeutic intervention for individuals at high risk of chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and related outcomes. He has over 75 publications, including over 60 original articles and more than 20 first or senior author manuscripts. Currently, he is funded by an NIH K08 award and has a sponsored research award from Genentech. He has been recognized with several early career physician-scientist awards including from National Jewish Health, the ATS Section on Genetics and Genomics, and the American Society for Clinical Investigation.